BEAM THERAPEUTICSCS INC
BEAM THERAPEUTICSCS INC
Acción · US07373V1052 · BEAM (XNAS)
Resumen Indicadores financieros
17,11 USD
-2,23 % -0,39 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
13.06.2025 22:57

Cotizaciones actuales de BEAM THERAPEUTICSCS INC

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
BEAM
USD
13.06.2025 22:57
17,11 USD
17,44 USD
-1,89 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -9,67 % -5,21 % -31,72 % -38,74 % -32,21 % -31,40 %

Firmenprofil zu BEAM THERAPEUTICSCS INC Aktie

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Investierte Fonds

Folgende Fonds haben in investiert: BEAM THERAPEUTICSCS INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
236,27
Anteil (%)
0,55 %

Unternehmensdaten

Name BEAM THERAPEUTICSCS INC
Firma Beam Therapeutics Inc.
Symbol BEAM
Website https://www.beamtx.com
Heimatbörse XNAS NASDAQ
ISIN US07373V1052
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. John M. Evans M.B.A.
Marktkapitalisierung 2 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,5 T
Adresse 238 Main Street, 02142 Cambridge
IPO Datum 2020-02-06
Dividenden von 'BEAM THERAPEUTICSCS INC'
Ex-Datum Dividende pro Aktie
04.02.2014 0,23 USD
04.11.2013 0,23 USD
12.08.2013 0,23 USD
06.05.2013 0,23 USD
04.02.2013 0,23 USD
05.11.2012 0,21 USD
06.08.2012 0,21 USD
07.05.2012 0,21 USD
06.02.2012 0,21 USD
07.11.2011 0,19 USD

Ticker Symbole

Name Symbol
NASDAQ BEAM

Weitere Aktien

Investoren die BEAM THERAPEUTICSCS INC die halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
DWS BALANCE
DWS BALANCE Fonds
GILEAD SCIENCES INC
GILEAD SCIENCES INC Aktie
ILLUMINA INC
ILLUMINA INC Aktie
INTEL CORP
INTEL CORP Aktie
INVESTAR HOLDING CORP
INVESTAR HOLDING CORP Aktie
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Aktie
QIAGEN NV (alt)
QIAGEN NV (alt) Aktie
REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC Aktie
SCHUMAG AG
SCHUMAG AG Aktie
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Aktie
YUM BRANDS 2037
YUM BRANDS 2037 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025